mHealth Technology and CVD Risk Reduction

Maan Isabella Cajita1, Yaguang Zheng2, Jacob Kigo Kariuki3

  • 1College of Nursing, University of Illinois at Chicago, 845 S. Damen Ave., Room 756, Chicago, IL, USA. mcajit2@uic.edu.

Insights

Mobile health (mHealth) interventions show potential for reducing cardiovascular disease (CVD) risk factors. However, evidence for their effectiveness is mixed, with varying results across weight loss, physical activity, smoking cessation, diabetes, and hypertension interventions.

Area of Science:

  • Digital health
  • Cardiovascular disease prevention
  • Public health interventions

Background:

  • Cardiovascular disease (CVD) remains a leading cause of mortality globally.
  • Lifestyle modifications are crucial for managing CVD risk factors.
  • Mobile health (mHealth) offers a scalable platform for health interventions.

Purpose of the Study:

  • To systematically review mHealth interventions aimed at reducing CVD risk factors.
  • To evaluate the efficacy of these digital health strategies.

Main Methods:

  • A comprehensive literature search identified 50 relevant articles.
  • Interventions focused on weight loss, physical activity, smoking cessation, diabetes management (HbA1c), and hypertension (blood pressure).
  • Included randomized controlled trials (RCTs) and other study designs.

Main Results:

  • mHealth interventions demonstrated varied success: 4/9 for weight loss, 4/7 for physical activity, 4/8 for smoking cessation, 5/10 for HbA1c reduction, and 3/9 for blood pressure reduction.
  • Most interventions targeted single CVD risk factors, with a few addressing multiple factors.
  • Evidence for efficacy in mitigating cardiovascular risk is heterogeneous.

Conclusions:

  • mHealth interventions are increasingly being developed to target CVD risk factors.
  • Despite promising potential, the current evidence base shows inconsistent efficacy.
  • Further research is needed to optimize mHealth strategies for cardiovascular risk reduction.
Abstract

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
89
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
441
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
114
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
99
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
576
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
207